Trials / Sponsors / Velicept Therapeutics, Inc.
Velicept Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women Overactive Bladder | Phase 2 | 2018-07-09 |
| Completed | Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women Overactive Bladder | Phase 2 | 2018-02-19 |
| Completed | Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Health Healthy Subjects, Overactive Bladder | Phase 1 | 2016-10-01 |